NB
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
12.35
Exchange
XNAS - Nasdaq
0.065 B
Last period CFO ,USD
1%
CFO has increased in 5 years
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also Neurocrine
Company Analysis
NBIX valuation, rating, competitors, insights and company profile
Eyestock Rating
NBIX financial analysis by Eyestock methodology
Valuation
NBIX valuation using historical relative method
Statements
NBIX Income Statements, Balance Sheet and Cash Flow Statements
Dividends
NBIX dividend yield and annual dividend
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
Neurocrine`s CFO for the period ended 2024-06-30 is 0.065 B USD
